http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Bringing transparency and accountability to pharmacy benefit managers
hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighteenth Congress, first session, February 16, 2023
Committee on Commerce, Science, and Transportation,
1 online resource (iv, 88 pages) : illustration.
In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Associated bill citation(s): S. 127; H.R. 830.
GPO Cataloging Record Distribution Program (CRDP).
Hearing witnesses: Hon. Chuck Grassley, U.S. Senator from Iowa; Ryan Oftebro, PharmD, FACA, CEO, Kelley-Ross Pharmacy Group; Debra Patt, M.D., PH.D., M.B.A., Oncologist, Texas Oncology; Erin Trish, Ph.D., Co-Director, Leonard D. Schaeffer Center for Health Policy & Economics, Associate Professor of Pharmaceutical and Health Economics, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California; Casey B. Mulligan, Professor of Economics and Program Director of The Initiative on Enabling Choice and Competition in Healthcare, University of Chicago.
United States. Congress. Senate. Committee on Commerce, Science, and Transportation.